| Gene symbol | HBB | Synonyms | CD113t-C, ECYT6, beta-globin | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p15.4 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | hemoglobin subunit beta | ||||
| GTO ID | GTC2008 |
| Trial ID | NCT03728322 |
| Disease | Thalassemia |
| Altered gene | HBB |
| Therapeutic/Target gene | Target gene |
| Therapy | Gene editing |
| Treatment | HBB gene corrected iHSCs |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | A Safety and Efficacy Study of a Single Center, Open-label, Single Arm About the Gene Correction of HBB in Patient-specific iHSCs Using CRISPR/Cas9 That Intervent Subjests With β-thalassemia Mutations |
| Year | 2018 |
| Country | China |
| Company sponsor | Allife Medical Science and Technology Co., Ltd. |
| Other ID(s) | HBB HSC-01 |
| Cohort 1 | |||||||
|
|||||||